Biotech Research & Innovation Centre (BRIC), University of Copenhagen

Belkins
Biotech Research & Innovation Centre (BRIC) was established in 2003 by the Danish Ministry of Science, Technology and Innovation. Today BRIC is a centre of excellence for biomedical research. The scientists in the centre focus on understanding the molecular mechanisms leading to various diseases, including cancer, CNS-related diseases and metabolic diseases.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

SCIENCE STUDENTS COMPETE FOR BIOTECH RESEARCH AWARDS

Biotech | January 05, 2017

news image

Student researchers will present their projects, with several scholars nominated for competitive CSU research awards. This year, 290 research posters from 22 CSU universities, including CSUF, were accepted for presentation. With more than 700 participants registered, it also is expected to be the largest symposium yet, organizers said....

Read More

MONSANTO GIFTS BIOTECH RESEARCH FACILITY TO UNIVERSITY OF WISCONSIN

kticradio | March 22, 2017

news image

Monsanto has donated a $10 million biotechnology research facility in Middleton, Wisconsin, to the University of Wisconsin, Madison, College of Agriculture. The facility, originally opened in 1982, features 20 greenhouses, 15,000 square feet of controlled environments, and 50,000 square feet of high-quality laboratory space on 4.5 acres. The state-of the-art facility was where researchers took the first critical steps in the development of plant biotechnology, and will now serve as the hub of th...

Read More

STEM CELL MODELS OF HUMAN SPINE DEVELOPMENT UNVEILED

Drug Target Review | January 15, 2020

news image

Scientists have created the first lab-dish models of the cellular clock, where each ‘tick’ stimulates the formation of the vertebra, which uses stem cells derived from adult human tissue. Over 20 years ago, Olivier Pourquié’s lab at Harvard University, US discovered a cellular clock in chicken embryos where each ‘tick’ stimulates the formation of a structure called a somite that ultimately becomes a vertebra. Now, Pourquié has led one of two teams to c...

Read More

BLUEBIRD BIO LAUNCHES FIRST GENE THERAPY FOR BETA THALASSEMIA IN GERMANY

Labiotech | January 15, 2020

news image

The US company bluebird bio has launched the first gene therapy for the blood disorder transfusion-dependent beta thalassemia in the EU, with a hospital in Germany becoming its first qualified treatment center. Bluebird bio’s gene therapy, branded as Zynteglo, was given conditional market approval by the EU in June 2019. It was the first gene therapy approved to treat people over 12 years of age with all but the most severe form of transfusion-dependent beta thalassemia, a condition that n...

Read More
news image

SCIENCE STUDENTS COMPETE FOR BIOTECH RESEARCH AWARDS

Biotech | January 05, 2017

Student researchers will present their projects, with several scholars nominated for competitive CSU research awards. This year, 290 research posters from 22 CSU universities, including CSUF, were accepted for presentation. With more than 700 participants registered, it also is expected to be the largest symposium yet, organizers said....

Read More
news image

MONSANTO GIFTS BIOTECH RESEARCH FACILITY TO UNIVERSITY OF WISCONSIN

kticradio | March 22, 2017

Monsanto has donated a $10 million biotechnology research facility in Middleton, Wisconsin, to the University of Wisconsin, Madison, College of Agriculture. The facility, originally opened in 1982, features 20 greenhouses, 15,000 square feet of controlled environments, and 50,000 square feet of high-quality laboratory space on 4.5 acres. The state-of the-art facility was where researchers took the first critical steps in the development of plant biotechnology, and will now serve as the hub of th...

Read More
news image

STEM CELL MODELS OF HUMAN SPINE DEVELOPMENT UNVEILED

Drug Target Review | January 15, 2020

Scientists have created the first lab-dish models of the cellular clock, where each ‘tick’ stimulates the formation of the vertebra, which uses stem cells derived from adult human tissue. Over 20 years ago, Olivier Pourquié’s lab at Harvard University, US discovered a cellular clock in chicken embryos where each ‘tick’ stimulates the formation of a structure called a somite that ultimately becomes a vertebra. Now, Pourquié has led one of two teams to c...

Read More
news image

BLUEBIRD BIO LAUNCHES FIRST GENE THERAPY FOR BETA THALASSEMIA IN GERMANY

Labiotech | January 15, 2020

The US company bluebird bio has launched the first gene therapy for the blood disorder transfusion-dependent beta thalassemia in the EU, with a hospital in Germany becoming its first qualified treatment center. Bluebird bio’s gene therapy, branded as Zynteglo, was given conditional market approval by the EU in June 2019. It was the first gene therapy approved to treat people over 12 years of age with all but the most severe form of transfusion-dependent beta thalassemia, a condition that n...

Read More